Canaccord Genuity Assumes AcelRx Pharmaceuticals (ACRX) at Buy, Catalyst-Heavy
Tweet Send to a Friend
Canaccord Genuity assumes coverage on AcelRx Pharmaceuticals (NASDAQ: ACRX) with a Buy. PT $8.00.
"We’re assuming coverage of AcelRx ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
"We’re assuming coverage of AcelRx ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
